Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring ...

In July, Embecta, a manufacturer of disposable insulin pen needles and syringes, said it is considering a potential sale following a significant drop in its share price since being spun off from ...

Q4 2024 Earnings Call Transcript November 26, 2024 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...

Good day, and welcome to the Embecta Fourth Quarter of Fiscal Year ... which occurred in Q4 as well as the launch of a small-pack GLP-1 pen needle set in Germany, with the intent to address ...

the recent launch of our small-pack GLP-1 needles in Germany has gone well, and we are evaluating expanding into other markets,” said Devdatt (Dev) Kurdikar, Chief Executive Officer of embecta ...

After TIME magazine named Taylor Swift "person of the year" in 2023 amid her global Eras Tour, she solidified her position as a cultural phenomenon, specifically among young women. Then, when she ...

embecta Corp. (embecta ... manufacturing approximately 8 billion insulin syringes and pen needles annually for about 30 million people across more than 100 countries. In honor of the occasion ...

Add articles to your saved list and come back to them any time. This story is part of the November 24 edition of Sunday Life.See all 14 stories. I’m back in the saddle to test-drive four non ...